Psychotropic drugs and medical conditions / Faruk Uguz, editor.
Material type: TextSeries: Psychiatry- theory, applications, and treatments seriesPublisher: New York : Nova Biomedical, [2017]Description: 1 online resourceContent type:- text
- computer
- online resource
- 9781536119589
- 153611958X
- 615.788 23
- RM315
Item type | Home library | Collection | Call number | Materials specified | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Electronic-Books | OPJGU Sonepat- Campus | E-Books EBSCO | Available |
Includes bibliographical references and index.
Online resource; title from PDF title page (EBSCO, viewed June 27, 2017)
Preface; Acknowledgments; Chapter 1; Hematological Effects of Psychotropic Medications; Abstract; Introduction; Antipsychotic Medications; Second Generation Antipsychotic Drugs; Clozapine; Olanzapine; Risperidone and Paliperidone: Short-Acting and Long-Acting; Quetiapine; Ziprasidone; Aripiprazole; Iloperidone, Asenapine, and Lurasidone; First Generation Antipsychotic Drugs; Phenothiazines; Butyrophenones; Mood Stabilizer Medications; Carbamazepine; Oxcarbazepine; Divalproex; Lamotrigine; Lithium; Gabapentin; Pregabalin; Topiramate; Antidepressant Drugs
Selective Serotonin Reuptake InhibitorsBupropion; Selective Serotonin Norepinephrine Reuptake Inhibitors; Atypical Antidepressants; Tricyclic and Tetracyclic Antidepressants; Benzodiazepines; Buspirone; Management; Conclusion; References; Chapter 2; Psychotropic Drug-Induced Renal Toxicity and Electrolyte Imbalance; Abstract; Introduction; Role of Kidneys in Drug Metabolism and Homeostasis; Psychotropics Known to Cause Renal Impairment and Electrolyte Imbalance; Psychotropics Causing Renal Toxicity; Lithium; Reduced Urinary Concentrating Capacity; Effect on Glomerular Filtration Rate
Development of Nephrogenic Diabetes Insipidus (NDI)Other Renal Effects of Lithium; Antidepressants; Antipsychotics; Psychotropics Causing Electrolyte Imbalance; Psychotropic-Induced Hyponatremia (Table 3); Antidepressants; Antipsychotics; Mood Stabilizers; Psychotropic-Induced Hypernatremia (Table 4); Psychotropic-Induced Hypokalemia (Table 4); Antidepressants; Antipsychotics; Mood Stabilizers; Psychotropic-Induced Hyperkalemia (Table 4); Psychotropic-Induced Hypocalcemia (Table 4); Psychotropic-Induced Hypercalcemia (Table 4)
Risk Factors of Psychotropic Induced Renal Impairment and Electrolyte ImbalanceAge; Gender; Physical Health and Co-Morbid Physical Illness; History of Hyponatremia/Electrolyte Disturbances in the Past; Nature of Psychiatry Disorder; Use of Other Concomitant Medications; Dose of Psychotropic Drug Used; Duration of Treatment; How to Prevent?; Psychotropic-Induced Renal Impairment; Psychotropic-induced Electrolyte Imbalance; Management; Management of Psychotropic-induced Renal Impairment Due to Rhabdomyolysis; Management of Lithium-induced Nephrogenic Diabetes Insipidus (NDI)
Management of Lithium-Induced NephropathyTreatment of Lithium Toxicity and When to Go for Dialysis?; Psychotropic-Induced Electrolyte Imbalances; Hyponatremia; Management of Other Psychotropic-induced Electrolyte Imbalances; Conclusion; References; Chapter 3; Psychotropic Drug-Induced Hepatotoxicity; Abstract; Introduction; Antidepressants; Monoamine Oxidase (MAO) Inhibitors; Tricyclic Antidepressants; Selective Serotonin Reuptake Inhibitors; Serotonin Noradrenaline Reuptake Inhibitors; New Generation Antidepressants; Antipsychotic Agents; First Generation Antipsychotics (FGAs)
eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - Worldwide
There are no comments on this title.